The DOI matches its Crossref record; 654 of the 654 references it cites were found in a registry or an index.
Inhibitors of Protein Methyltransferases and Demethylases
Open accessAbstract
Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases. Many of these enzymes also target various nonhistone proteins impacting numerous crucial biological pathways. Given their key biological functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets. Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade. In this review, we cover the discovery, characterization, and biological application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field. We also discuss challenges, opportunities, and future directions in this emerging, exciting research field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 601–654 of 654
Hairless is a histone H3K9 demethylase
Liu, L., Kim, H.-M., Casta, A., Kobayashi, Y., Shapiro, L. S., & Christiano, A. M. (2013) · The FASEB Journal · doi:10.1096/fj.13-237677 · Cited by 49
Scheufler, C., Möbitz, H., Gaul, C., Ragot, C., Be, C., Fernández, C. F., Beyer, K. S., Tiedt, R., & Stauffer, F. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00168 · Cited by 49
Hu, H., Owens, E. A., Su, H., Yan, L., Levitz, A., Zhao, X., Henary, M., & Zheng, Y. G. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501452j · Cited by 48
Tavanez, J. P., Bengoechea, R., Berciano, M. T., Lafarga, M., Carmo‐Fonseca, M., & Enguita, F. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006418 · Cited by 48
Easmon, J., Heinisch, G., Pürstinger, G., Langer, T., Österreicher, J. K., Grunicke, H. H., & Hofmann, J. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970255w · Cited by 48
MMSET is the key molecular target in t(4;14) myeloma
Mirabella, F., Wu, P., Wardell, C. P., Kaiser, M., Walker, B. A., Johnson, D. C., & Morgan, G. J. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.9 · Cited by 47
Proteomic Dissection of the von Hippel–Lindau (VHL) Interactome
Lai, Y., Song, M., Hakala, K. W., Weintraub, S. T., & Shiio, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr200642c · Cited by 47
Activity-Based Protein Profiling of Protein Arginine Methyltransferase 1
Obianyo, O., Causey, C. P., Jones, J. E., & Thompson, P. R. (2011) · ACS Chemical Biology · doi:10.1021/cb2001473 · Cited by 47
Obianyo, O., Causey, C. P., Osborne, T. C., Jones, J. E., Lee, Y., Stallcup, M. R., & Thompson, P. R. (2010) · ChemBioChem · doi:10.1002/cbic.201000209 · Cited by 46
Identification of potent, selective KDM5 inhibitors
Gehling, V. S., Bellon, S. F., Harmange, J.-C., Leblanc, Y., Poy, F., Odate, S., Buker, S. M., Lan, F., Arora, S., Williamson, K. E., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.026 · Cited by 45
Nowotarski, S. L., Pachaiyappan, B., Holshouser, S. L., Kutz, C. J., Li, Y., Huang, Y., Sharma, S. K., Casero, R. A., & Woster, P. M. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.049 · Cited by 44
Butler, K. V., Ma, A., Yu, W., Li, F., Tempel, W., Babault, N., Pittella-Silva, F., Shao, J., Wang, J., Luo, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01244 · Cited by 44
Self-citationXie, Y., Zhou, R., Lian, F., Liu, Y., Chen, L., Shi, Z., Zhang, N., Zheng, M., Shen, B., Jiang, H., et al. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01591f · Cited by 43
Seth-Vollenweider, T., Joshi, S., Dhawan, P., Sif, S., & Christakos, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.583302 · Cited by 43
Dowden, J., Pike, R. A., Parry, R. V., Hong, W., Muhsen, U. A., & Ward, S. G. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob06100c · Cited by 41
LSD1 Histone Demethylase Assays and Inhibition
Hayward, D., & Cole, P. A. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.01.020 · Cited by 41
Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor
de Freitas, R. F., Eram, M. S., Szewczyk, M. M., Steuber, H., Smil, D. V., Wu, H., Li, F., Senisterra, G. A., Dong, A., Brown, P. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01772 · Cited by 40
PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase
Blazer, L. L., Lima‐Fernandes, E., Gibson, E., Eram, M. S., Loppnau, P., Arrowsmith, C. H., Schapira, M., & Vedadi, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721472 · Cited by 40
Rüger, N., Roatsch, M., Emmrich, T., Franz, H., Schüle, R., Jung, M., & Link, A. (2015) · ChemMedChem · doi:10.1002/cmdc.201500335 · Cited by 37
Zhou, Y., Li, Y., Wang, W., Pu, X., Luo, X., Li, Y., Yang, S., & Zhao, Y. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.054 · Cited by 36
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors
Cowen, S. D., Russell, D. J., Dakin, L. A., Chen, H., Larsen, N., Godin, R. E., Throner, S. R., Zheng, X., Molina, A., Wu, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01303 · Cited by 36
Napierala, J. S., Zurita‐Lopez, C. I., Clarke, S. G., Bedford, M. T., & Dent, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202416 · Cited by 35
PRMT3 is essential for dendritic spine maturation in rat hippocampal neurons
Miyata, S., Mori, Y., & Tohyama, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.033 · Cited by 35
Lee, Y., & Stallcup, M. R. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15379 · Cited by 34
RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20
Park, J. W., Kim, K., Kim, J., Chae, Y., Jeong, O.-S., & Seo, S. (2015) · Scientific Reports · doi:10.1038/srep12485 · Cited by 34
England, K. S., Tumber, A., Krojer, T. J., Scozzafava, G., Ng, S. S., Daniel, M., Szykowska, A., Che, K., von Delft, F., Burgess-Brown, N., et al. (2014) · MedChemComm · doi:10.1039/c4md00291a · Cited by 33
Structure–activity relationship studies of SETD8 inhibitors
Ma, A., Yu, W., Xiong, Y., Butler, K. V., Brown, P. J., & Jin, J. J. (2014) · MedChemComm · doi:10.1039/c4md00317a · Cited by 33
Self-citationSmall molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases
Wang, Z., & Patel, D. J. (2013) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583513000085 · Cited by 33
Chen, S., Li, L., Chen, Y., Hu, J., Liu, J., Liu, J. Y.-C., Liu, R., Zhang, Y., Meng, F., Zhu, K., et al. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00738 · Cited by 33
A Chemical Tool for In Vitro and In Vivo Precipitation of Lysine Methyltransferase G9a
Konze, K. D., Pattenden, S. G., Liu, F., Baršytė-Lovejoy, D., Li, F., Simon, J. M., Davis, I. J., Vedadi, M., & Jin, J. J. (2014) · ChemMedChem · doi:10.1002/cmdc.201300450 · Cited by 32
Self-citationZhou, C., Kang, D., Xu, Y., Zhang, L., & Zha, X. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12461 · Cited by 30
H3K9 histone methyltransferase G9a‐mediated transcriptional activation of p21
Oh, S.-T., Kim, K., Chae, Y., Kang, J., Hahn, Y., & Seo, S. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.039 · Cited by 30
Lin, H., Wang, Y., Wang, Y., Tian, F., Pu, P., Yu, Y., Mao, H., Yang, Y., Wang, P., Hu, L., et al. (2010) · Cell Research · doi:10.1038/cr.2010.84 · Cited by 30
Histone H3 peptide based LSD1-selective inhibitors
Kakizawa, T., Ota, Y., Itoh, Y., Tsumoto, H., & Suzuki, T. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.03.030 · Cited by 29
Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human
Waters, N. J., Smith, S. A., Olhava, E. J., Duncan, K. W., Burton, R. D., O’Neill, J., Rodrigue, M.-È., Pollock, R. M., Moyer, M. P., & Chesworth, R. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2929-y · Cited by 28
Khan, M. N. A., Tsumoto, H., Itoh, Y., Ota, Y., SUZUKI, M. T., Ogasawara, D., Nakagawa, H., Mizukami, T., Miyata, N., & Suzuki, T. (2014) · MedChemComm · doi:10.1039/c4md00330f · Cited by 27
Williams, D. E., Izard, F., Arnould, S., Dalisay, D. S., Tantapakul, C., Maneerat, W., Matainaho, T. K., Julien, E., & Andersen, R. J. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02569 · Cited by 26
Spurr, S. S., Bayle, E. D., Yu, W., Li, F., Tempel, W., Vedadi, M., Schapira, M., & Fish, P. V. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.041 · Cited by 26
Kanıskan, H. Ü., Eram, M. S., Liu, J., Smil, D. V., Martini, M. L., Shen, Y., Santhakumar, V., Brown, P. J., Arrowsmith, C. H., Vedadi, M., et al. (2016) · MedChemComm · doi:10.1039/c6md00342g · Cited by 25
Self-citationDiscovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations
Ji, S., Ma, S., Wang, W., Huang, S., Wang, T., Xiang, R., Hu, Y., Chen, Q., Li, L., & Yang, S. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12881 · Cited by 25
Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacement
Yi, J. S., Alexander Joel Federation, Qi, J., Dhe‐Paganon, S., Hadler, M., Xu, X., Pierre, R. S., Varca, A. C., Wu, L., Marineau, J., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500796d · Cited by 22
Feng, T., Li, D., Wang, H., Zhuang, J., Liu, F., Bao, Q., Lei, Y., Chen, W., Zhang, X., Xu, X., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.013 · Cited by 22
Quantitative Analysis of Histone Demethylase Probes Using Fluorescence Polarization
Xu, W., Podoll, J. D., Dong, X., Tumber, A., Oppermann, U. C. T., & Wang, X. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3018628 · Cited by 20
Hu, J., Wang, X., Chen, L., Huang, M., Tang, W., Zuo, J., Liu, Y., Shi, Z., Liu, R., Shen, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.006 · Cited by 20
Roatsch, M., Robaa, D., Pippel, M., Nettleship, J. E., Reddivari, Y., Bird, L. E., Hoffmann, I., Franz, H., Owens, R. J., Schüle, R., et al. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc.15.188 · Cited by 19
Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors
Labadie, S. S., Dragovich, P. S., Cummings, R. T., Deshmukh, G. S., Gustafson, A. E., Han, N., Harmange, J.-C., Kiefer, J. R., Li, Y., Liang, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.070 · Cited by 19
An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors
Mannironi, C., Proietto, M., Bufalieri, F., Cundari, E., Alagia, A. A., Danovska, S., Rinaldi, T., Famiglini, V., Coluccia, A., Regina, G. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086002 · Cited by 18
Wang, W., Marholz, L. J., & Wang, X. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115579637 · Cited by 18
Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8
Judge, R. A., Zhu, H., Upadhyay, A. K., Bodelle, P. M., Hutchins, C. W., Torrent, M., Marin, V. L., Yu, W., Vedadi, M., Li, F., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00303 · Cited by 18
Langley, G. W., Brinkø, A., Münzel, M., Walport, L. J., Schofield, C. J., & Hopkinson, R. J. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00738 · Cited by 17
Francis, N.-J., Rowlands, M., Workman, P., Jones, K., & Aherne, W. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112452137 · Cited by 15
Development of Substrate-Selective Probes for Affinity Pulldown of Histone Demethylases
Marholz, L. J., Chang, L., Old, W. M., & Wang, X. (2014) · ACS Chemical Biology · doi:10.1021/cb5006867 · Cited by 13
Gao, T., Zhang, L., Zhu, Y., Song, X., Feng, Q., Lei, Q., Shi, S., Deng, H., Xiong, M., You, X., et al. (2016) · RSC Advances · doi:10.1039/c6ra00618c · Cited by 11
Chi, S. N., McCowage, G. B., Hoffman, L., Macy, M., Doleman, S., Blakemore, S. J., Clawson, A., Daigle, S., Tang, J., Roche, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.tps10587 · Cited by 8
Cited by
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
Self-citationLSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Biswas, S., & Rao, C. M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.021 · Cited by 389
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
Metadata
- Authors
- Kaniskan, H. Ü., Martini, M. L., & Jin, J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-24
- Volume
- 118
- Issue
- 3
- Pages
- 989-1068
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2602027562
- Cited by
- 297
- References
- 654
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.